Evidence of a polyclonal nature of myositis ossificans

被引:6
作者
Leithner, A
Weinhaeusel, A
Zeitlhofer, P
Koch, H
Radl, R
Windhager, R
Beham, A
Haas, OA
机构
[1] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria
[2] Med Univ Graz, Dept Orthoped Surg, Graz, Austria
[3] Med Univ Graz, Dept Surg, Div Plast Surg, Graz, Austria
[4] Med Univ Graz, Inst Pathol, Graz, Austria
关键词
myositis ossificans; DNA methylation; X inactivation; polymerase chain reaction; FMR1;
D O I
10.1007/s00428-004-1169-z
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Myositis ossificans is a localized, self-limiting, reparative lesion that is composed of reactive hypercellular fibrous tissue and bone. Although it is clearly a benign lesion, its clinical, radiological, and histological appearance may sometimes mimic a malignant tumor. Whether myositis ossificans represents a monoconal or polyclonal hyperplastic proliferation is not yet known. To address this question, we therefore extracted DNA from the respective paraffin-embedded tumor tissues of nine women with a median age of 50 years at diagnosis ( range: 20 - 84 years) and studied the X inactivation pattern by means of methylation-sensitive polymerase chain reaction and primers that target the polymorphic CGG trinucleotide repeat of the FMR1 gene. The fact that we did not detect any skewing of the X inactivation pattern in the five successfully analyzed cases corroborates the notion that myositis ossificans results from a polyclonal proliferation and confirms that it is a reactive, reparative process. Analysis of the X inactivation pattern may, thus, supplement the differential diagnostic work-up of cases with an uncertain histology, at least in the informative proportion of female patients.
引用
收藏
页码:438 / 441
页数:4
相关论文
共 9 条
[1]   MYOSITIS-OSSIFICANS - MR APPEARANCE WITH RADIOLOGIC-PATHOLOGICAL CORRELATION [J].
KRANSDORF, MJ ;
MEIS, JM ;
JELINEK, JS .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 157 (06) :1243-1248
[2]   Desmoid fibromatosis is a clonal process [J].
Li, MM ;
CordonCardo, C ;
Gerald, WL ;
Rosai, J .
HUMAN PATHOLOGY, 1996, 27 (09) :939-943
[3]  
McDonald HL, 2000, GENE CHROMOSOME CANC, V28, P246, DOI 10.1002/1098-2264(200007)28:3<246::AID-GCC2>3.3.CO
[4]  
2-S
[5]  
MIRRA JM, 1989, BONE TUMORS CLIN RAD, P1550
[6]  
NUOVO MA, 1992, SKELETAL RADIOL, V21, P87
[7]  
RESNICK D, 1981, DIAGNOSIS BONE JOINT, P3152
[8]  
Rosenberg AE, 2002, PATHOLOGY GENETICS T, P52
[9]   Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR [J].
Weinhäusel, A ;
Haas, OA .
HUMAN GENETICS, 2001, 108 (06) :450-458